
================================================================================
=== DOCUMENT 1: 8-K - ahr-20241107.htm ===
================================================================================

ahr-20241107
FALSE
0001632970
0001632970
2024-11-07
2024-11-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
November 7, 2024
American Healthcare REIT, Inc.
(Exact name of registrant as specified in its charter)
Maryland
001-41951
47-2887436
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
18191 Von Karman Avenue
,
Suite 300
Irvine
,
California
92612
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:
(
949
)
270-9200
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
AHR
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
On November 7, 2024, we held our 2024 Annual Meeting of Stockholders. At the meeting, our stockholders voted on the following four proposals: (i) to consider and vote upon the election of nine directors, each to hold office for a one-year term expiring at the 2025 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies; (ii) to consider and vote upon the ratification of the appointment of Deloitte & Touche LLP, or Deloitte & Touche, as our independent registered public accounting firm for the year ending December 31, 2024; (iii) to approve, on an advisory (non-binding) basis, the compensation paid to our named executive officers for the year ended December 31, 2023; and (iv) to approve the American Healthcare REIT, Inc. 2024 Employee Stock Purchase Plan. The four proposals are described in detail in our definitive proxy statement, dated August 28, 2024, as filed with the United States Securities and Exchange Commission on Schedule 14A on August 28, 2024.
The votes with respect to each of the proposals are set forth below.
Proposal 1.   To consider and vote upon the election of nine directors, each to hold office for a one-year term expiring at the 2025 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies:
Nominee
Shares For
Shares Withheld
Broker Non-Votes
Jeffrey T. Hanson
71,063,216
2,883,039
33,651,003
Danny Prosky
72,903,753
1,042,502
33,651,003
Mathieu B. Streiff
71,612,152
2,334,103
33,651,003
Scott A. Estes
72,633,788
1,312,467
33,651,003
Brian J. Flornes
37,035,533
36,910,722
33,651,003
Dianne Hurley
72,969,037
977,218
33,651,003
Marvin R. O'Quinn
72,894,899
1,051,356
33,651,003
Valerie Richardson
47,601,108
26,345,147
33,651,003
Wilbur H. Smith III
46,616,328
27,329,927
33,651,003
The nine above-referenced nominees therefore were elected as our directors by the requisite vote of our stockholders necessary for approval.
Proposal 2.  To consider and vote upon the ratification of the appointment of Deloitte & Touche as our independent registered public accounting firm for the year ending December 31, 2024:
Shares For
Shares Against
Shares Abstained
106,436,665
836,848
323,745
The appointment of Deloitte & Touche as our independent registered public accounting firm for the year ending December 31, 2024, therefore was ratified by the requisite vote of our stockholders necessary for approval.
Proposal 3.   To approve, on an advisory (non-binding) basis, the compensation paid to our named executive officers for the year ended December 31, 2023:
Shares For
Shares Against
Shares Abstained
Broker Non-Votes
71,399,556
1,871,807
674,892
33,651,003
The compensation of our named executive officers therefore was approved by the requisite vote of our stockholders, on an advisory basis.
Proposal 4.   To approve the American Healthcare REIT, Inc. 2024 Employee Stock Purchase Plan:
Shares For
Shares Against
Shares Abstained
Broker Non-Votes
72,847,137
611,303
487,815
33,651,003
The American Healthcare REIT, Inc. 2024 Employee Stock Purchase Plan
therefore was approved by the requisite vote of our stockholders
.
No other proposals were submitted to a vote of our stockholders at the annual meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
American Healthcare REIT, Inc.
November 8, 2024
By:
/s/ Danny Prosky
Name: Danny Prosky
Title: Chief Executive Officer and President

